WW International relists on Nasdaq, pivoting to menopause care with GLP-1 drugs and coaching. Click here to read an analysis ...

The Canadian Dollar continues to struggle with holding onto near-term gains, and the USD/CAD pair is strung along a growing consolidation zone just below the 1.3700 handle. Ongoing CAD weakness, or ...

SoFi Technologies (SOFI) has transformed from a student‑loan refi‑focused startup into a leading digital financial hub, ...

Tesla stock chart signals fresh trouble as bearish trend deepens despite brief rally- Tesla stock continues to face intense pressure as its recent rally fades and bearish signals strengthen. Despite a ...

Constellation Brands posted lower profit and sales in its most recent quarter, as widespread consumer weakness, including among its core Hispanic demographic, continued to weigh on sales of beer ...

Porsche AG warned of a tough road ahead for sales this year after a slowdown in the lucrative US market and persistent weakness in China.

The sneaker and athletic apparel company expects the decline in its sales and margins to slow in the current quarter as it continues to clear aged inventory and crank up marketing.

June 26 (Reuters) - Novo Nordisk (NOVOb.CO) said on Thursday it will collaborate with WeightWatchers to sell its blockbuster weight-loss drug Wegovy, starting July 1.

The growing popularity of weight loss jabs could be affecting shopping habits in UK supermarkets, a leading research group has said, as 4 per cent of households are now using them. The amount of ...

Nike expects its sales decline to decelerate in the current quarter as its turnaround strategy progresses. The sportswear brand said Thursday it expects sales in its fiscal first quarter to drop ...

Shares of Nike rose after the sportswear giant said it expects the decline in its sales and margins to decelerate in the current quarter as its comeback strategy progresses. The stock rose 16% to ...

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.